Epilepsy is a significant comorbid condition in institutionalized persons with developmental disabilities and may contribute significant additional costs.
This study was conducted to provide an estimate of the costs of epilepsy from the institutional perspective.
Costs were measured retrospectively for 50 persons with epilepsy and 50 persons without epilepsy matched by severity of developmental disability.
A time and motion study was employed to assign opportunity costs to documented nursing and physician activities.
Two separate methods of attribution were used and incremental costs attributable to epilepsy were found to be approximately $825 and $918 per person over a 6-month period.
The following categories accounted for costs : personnel (47.0%), drug (39.6%), hospitalization (9.4%), and laboratories/procedures (4.0%). Results are useful for describing the economic burden of epilepsy.
Mots-clés Pascal : Arriération mentale, Association morbide, Epilepsie, Institution spécialisée, Coût financement, Santé mentale, Etats Unis, Amérique du Nord, Amérique, Homme, Déficience intellectuelle, Trouble développement, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie
Mots-clés Pascal anglais : Mental retardation, Concomitant disease, Epilepsy, Specialized institution, Financing cost, Mental health, United States, North America, America, Human, Intellectual deficiency, Developmental disorder, Nervous system diseases, Central nervous system disease, Cerebral disorder
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0332449
Code Inist : 002B18H05B. Création : 16/11/1999.